Results 41 to 50 of about 717,165 (311)

Rethinking monogenic neurological diseases [PDF]

, 2020
Studies on monogenic diseases can provide valuable insights into the mechanisms of other neurological disorders, say Wan-Jin Chen and ...
Cheng, X, Fu, Y, Chen, WJ, Xiong, ZQ, McGinley, J, Westenberger, A, Zhao, M   +6 more
core   +1 more source

The Role of Hematopoietic Cell Transplantation in Ataxia‐Telangiectasia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Ataxia‐telangiectasia (A‐T) is a DNA repair disorder characterized by neurodegeneration, immunodeficiency, and cancer predisposition. Hematopoietic cell transplantation (HCT) is an established therapy in related disorders such as Fanconi anemia (FA) and Nijmegen breakage syndrome (NBS), but its role in A‐T is unclear.
Laila Alkhouli, Seth Rotz, Masatoshi Takagi, Richa Sharma   +3 more
wiley   +1 more source

Physical Restraints in a Mental Hospital Emergency Unit: Facts vs Perceptions of Healthcare Workers

European Psychiatry, 2023
Introduction Coercion is a general term used to refer to a series of actions, ranging from involuntary treatments to forced interventions, which can be ethically, legally and clinically challenging for both professionals and service-users. Perception of
E. Sönmez Güngör, E. Poyraz, B. N. Güvendi, M. Eriş, O. Durmaz   +4 more
doaj   +1 more source

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi, Daisuke Katagiri, Takeyuki Watadani, Shunichi Matsuda, Hiroshi Kaneko, Noritoshi Arai   +5 more
wiley   +1 more source

Blood levels of Glial Fibrillary Acidic Protein (GFAP) in patients with neurological diseases

, 2013
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate indicative of intracerebral hemorrhage in patients with symptoms suspicious of acute stroke.
Niessner, Marion, Robert Brunkhorst, Brunkhorst, Robert, Helmuth Steinmetz, Steinmetz, Helmuth, Marion Niessner, Mayer, Christoph, Christian Foerch, Pfeilschifter, Waltraud, Christoph A Mayer, Förch, Christian, Waltraud Pfeilschifter   +11 more
core   +1 more source

Immunotherapy for neurological diseases [PDF]

, 2013
This review is based in a symposium organized in May 2007 by the Fundacion Ramon Areces, Madrid, a non-profit organization dedicated to promote scientific research (http://www.fundacionareces.es/).The burden of neurological diseases in western societies ...
Khoury, Sarnia J., Moreno, Beatriz, Acarin, Laia, Uccelli, Antonio, Appel, Stanley, Melero, Ignacio, Ávila, Jesús, Martino, Gianvito, Ferrer, Isidro, Rivest, Serge, Montalbán, Xavier, McGeer, Patrick, Villoslada, Pablo, Obeso, José Ángel, Delgado, Mario, Pablos, José Luis, Schwartz, Michal   +16 more
core   +1 more source

Potential Protein Signatures for Recurrence Prediction of Ischemic Stroke

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Acute ischemic stroke is a major cause of mortality and disability worldwide, with approximately 7.4% to 7.7% recurrence within the first 3 months. This study aimed to identify potential biomarkers for predicting stroke recurrence. Methods and
Chengyi Zhang, Yang Liu, Huimin Zhu, Xinying Huang, Cang Guo, Si Cheng, Meng Yuan, Yong Jiang, Xia Meng, S. Claiborne Johnston, Yongjun Wang, Wei‐Na Jin, Fu‐Dong Shi   +12 more
doaj   +1 more source

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho, Karim M. Soliman, Wisit Cheungpasitporn, Wannasit Wathanavasin, Ahmed Daoud, Ahmed I. Kamal, Balázs Szamosfalvi, Tibor Fülöp   +7 more
wiley   +1 more source

cell therapy in neurological diseases

, 2023
Genetically modified immune cells, especially CAR-T cells, have captured the attention of scientists over the past 10 years. In the fight against cancer, these cells have a special place.
Siamak Sandoghchian Shotorbani, Kookli, K., Narges Soltani, Mahdi Zarei, Shahabifard, H., Hesam Shahabifard, Afyouni, N. E., Keihan Kookli, Ali Adili, Nazgol Esmalian Afyouni, Sairan Maghsoodi, Javad Mahmoudi, Adili, A., Shotorbani, S. S., Shomali, N., Maghsoodi, S., Mahmoudi, J., Zarei, M., Navid Shomali, Soltani, N.   +19 more
core   +1 more source

Ferroptosis in Neurological Diseases

Frontiers in Cellular Neuroscience, 2020
Ferroptosis is mechanism for non-apoptotic, iron-dependent, oxidative cell death that is characterized by glutathione consumption and lipid peroxides accumulation.
Jia-Xin Ren, Jia-Xin Ren, Xin Sun, Xiu-Li Yan, Zhen-Ni Guo, Yi Yang   +5 more
doaj   +1 more source